Long COVID: Could antiplatelet therapy help?
Companies, agencies, institutions, etc
The Centers for Disease Control and Prevention
CDC
COVID-19
Stellenbosch University
Apixiban
University College London
ICP
COVID.He
Medical News Today
University College London Hospitals
MNT
Omicron
People
Pantoprazole
Amitava Banerjee
Rivaroxaban
Apixiban
Amitava BanerjeeDr
Melissa Heightman
Groups
COVID-19
them?An
Physical locations
No matching tags
Places
No matching tags
Locations
South Africa
COVID-19.Many
Events
No matching tags
Summary
This work formed the basis of the so-called microclot model, which proposes that small clots in the blood capillaries that prevent oxygen from reaching the tissues may cause long COVID symptoms. The team analyzed blood samples from 70 people with confirmed long COVID to detect microclots. The team found that all 70 participants had microclots in their blood and that all 24 people who received the antiplatelet and anticoagulant therapy reported improvements in their long COVID symptoms; they also saw a reduction of microclots.
As said here by Hannah Flynn